As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
drug
New hope in the fight against sickle cell disease
For Mary Long, the answer to her pain may, literally, be right around the corner.
OMRF enters into a license agreement with Shanghai RAAS Blood Products
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
OMRF researcher tests new approach for treating deadly blood infection
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
